from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0449c/-

LFCtreatmentdescriptionclass of inhibitor

0.033

Amikacinug/mL Amikacintranslation

-0.206

Cap5-10ug/mL Capreomycintranslation

-0.133

Rox10-50 ug/mL Roxithromycintranslation

-0.611

SM2-5 ug/mL Streptomycintranslation

-0.473

Tet5-10 ug/mL Tetracyclinetranslation

1.375

Rif0.2-5ug/mL Rifampicintranscription

1.042

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.799

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.343

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.139

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.691

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.856

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.352

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.210

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.771

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.644

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.701

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.222

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.535

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.575

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.599

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.050

Nigericin50 uM Nigericinrespiration

0.562

TRC10-150 ug/mL Triclosanrespiration

0.384

TRZ10-25 ug/mL Thioridazinerespiration

0.362

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.398

menadione6-10 ug/mL Menadionerespiration

0.851

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.174

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.404

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.427

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.719

NRP_1Non-replicating persistence stage 1dosRassociated

-0.441

Amp0.2mg/mL AmpicillincellWall

-0.582

Cephalexin20-100 ug/mL CephalexincellWall

-0.365

Cerulenin0.32-5 ug/mL CerulenincellWall

0.242

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.583

EMB10-20 ug/mL EthambutolcellWall

-1.032

Eta12-40 ug/mL EthionamidecellWall

-1.140

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.111

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.003

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.423

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.212

BZA0.12 mg/mL BenzamidearomaticAmides

-0.645

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.015

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.303

H2O24 mM hydrogen peroxideDNAdamaging

-0.006

Levo10 ug/mL LevofloxacinDNAdamaging

-0.225

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.614

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.061

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.211

UVUV-irradiationDNAdamaging

0.665

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.108

Antimycin12.5-50 ug/mL Antimycin A?

-0.540

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.341

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.043

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.623

PA8240.2-2 ug/mL PA-824?

0.046

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.457

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.275

Verapamil50 uM Verapamil?

-0.023

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.583

methoxatin10-20 ug/mL Methoxatin?